Morgan Stanley Issues Positive Forecast for Arxis (NASDAQ:ARXS) Stock Price

Arxis (NASDAQ:ARXS) had its price target upped by equities researchers at Morgan Stanley from $62.00 to $66.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley‘s target price suggests a potential upside of 31.40% from the stock’s previous close.

Several other research firms have also commented on ARXS. Weiss Ratings upgraded Arxis from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, October 8th. Citigroup raised their price target on shares of Arxis from $61.00 to $67.00 and gave the company a “buy” rating in a report on Thursday, August 13th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $60.00 price objective on shares of Arxis in a research report on Sunday, August 2nd. Royal Bank Of Canada increased their price target on shares of Arxis from $60.00 to $64.00 and gave the stock an “outperform” rating in a report on Friday. Finally, Wells Fargo & Company increased their price target on shares of Arxis from $52.00 to $63.00 and gave the stock an “overweight” rating in a report on Tuesday, August 4th. Eleven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Arxis presently has a consensus rating of “Moderate Buy” and an average target price of $55.36.

Arxis Stock Down 8.6%

Shares of ARXS stock traded down $4.70 during trading hours on Friday, hitting $50.23. 438,022 shares of the company’s stock traded hands, compared to its average volume of 1,033,875. The firm has a market cap of $20.97 billion and a PE ratio of 627.88. The company has a debt-to-equity ratio of 0.38, a quick ratio of 3.79 and a current ratio of 5.21. The stock has a fifty day moving average price of $51.31. Arxis has a 12-month low of $33.15 and a 12-month high of $61.50.

Arxis (NASDAQ:ARXS) last released its quarterly earnings results on Wednesday, July 29th. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.35. The company had revenue of $500.73 million for the quarter. Arxis’s revenue for the quarter was up 25.0% on a year-over-year basis. On average, equities analysts forecast that Arxis will post 0.57 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Arxis

Hedge funds have recently modified their holdings of the business. Squarepoint Ops LLC acquired a new stake in shares of Arxis during the second quarter worth $19,506,000. Grandeur Peak Global Advisors LLC acquired a new position in Arxis during the 2nd quarter worth approximately $2,740,000. State Street Corp acquired a new stake in shares of Arxis during the second quarter worth approximately $9,948,000. Alyeska Investment Group L.P. bought a new position in shares of Arxis in the 2nd quarter worth about $13,842,000. Finally, Moody National Bank Trust Division acquired a new stake in shares of Arxis in the third quarter valued at approximately $1,113,000.

More Arxis News

Here are the key news stories impacting Arxis this week:

• Positive Sentiment: Arxis exceeded third-quarter expectations. The company reported earnings of $0.37 per share versus the $0.24 consensus estimate, while revenue rose 35.9% year over year to $563.98 million. Arxis Reports Third Quarter 2026 Results
• Positive Sentiment: Full-year 2026 guidance was raised. Arxis now expects approximately $2.1 billion in revenue, ahead of the roughly $2.0 billion analyst consensus. The company also introduced an outlook for 2027, supporting expectations for continued growth. Arxis Q3 Revenue Rises; 2026 Guidance Raised
• Positive Sentiment: Royal Bank of Canada raised its price target from $60 to $64 and maintained an “outperform” rating, implying substantial upside from the stock’s recent trading level. Royal Bank of Canada Recommendations
• Neutral Sentiment: Management’s third-quarter earnings call included discussion of the raised 2026 outlook and 2027 expectations, but the provided transcript listings do not disclose additional specific catalysts or risks. Arxis Q3 2026 Earnings Call Transcript
• Negative Sentiment: Valuation may be weighing on the shares. Despite the earnings beat and stronger guidance, Arxis has a very elevated price-to-earnings ratio, leaving less room for disappointment and potentially encouraging investors to lock in gains.

About Arxis

We are a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical components engineered for cutting-edge performance in extreme environments. Leveraging significant intellectual property (“IP”) and world-class engineering capabilities, we design and deliver innovative solutions that address some of our customers’ most complex performance needs. Arxis is the result of a deliberate and disciplined strategy executed by our sponsor, Arcline, and the Arxis management team to create a purpose-built, cohesive business through targeted acquisitions with similar product and end market characteristics.